Patents/Assignees

Eyepoint Pharmaceuticals, Inc.

14 patents in portfolio

US12551368utility2026
Bioerodible Ocular Drug Delivery Insert and Therapeutic Method
0 cites
US12544362utility2026
Methods of Treating Acute Respiratory Distress Syndrome with Activators of Tie-2
0 cites
USD1106444design2025
Ocular Injector
0 cites
US12329859utility2025
Bioerodible Drug Delivery Devices
0 cites
US12187715utility2025
Small Molecule Activators of Tie-2
0 cites
US12171751utility2024
Methods of Treating Intraocular Pressure with Activators of Tie-2
0 cites
US12152023utility2024
Compositions, Formulations and Methods for Treating Ocular Diseases
0 cites
US12145986utility2024
Method of Treating an Ocular Condition by Administering a Humanized Monoclonal Antibodies That Target VE-PTP (hptp-beta)
0 cites
USD1043969design2024
Ocular Injector
0 cites
US12064420utility2024
Tie-2 Activators Targeting the Schlemm's Canal
0 cites
US12043664utility2024
Methods for Treating Vascular Leak Syndrome and Cancer
0 cites
US11873334utility2024
Method of Treating Ocular Conditions by Administering an Antibody That Activates Tie2 and Binds VEGF
0 cites
US11666558utility2023
Methods of Treating Intraocular Pressure with Activators of Tie-2
0 cites
US11613534utility2023
Small Molecule Activators of Tie-2
0 cites